Other Titles
Women's Sexual Health
Abstract
Session presented on Saturday, July 25, 2015: Purpose: A pilot study was conducted for the inquiry of vaginal probiotics for menopausal women with self-reported dyspareunia. Methods: Initial menopausal survey tool for assessment of urinary incontinence, dyspareunia and general vasomotor complaints allowed for women with self-reported dyspareunia to be further evaluated. potential candidates where then contacted and offered the opportunity to participate in an open lable study using a vaginal probiotic once per week for 6 weeks. After full disclosure and IRB approved consent was signed, the subjects examined and vaginal ph measurement obtained. The Female Sexual Function Index (FSFI, 2002) was administered. After 6 weeks of intervention, the women returned, repeated the FSFI and were examined with vaginal ph reassesed. A diary of dates and times probiotic was used and sexual intercourse took place was kept during the study and turned in to the PI. Results: 107 menopausal women were screened, 37 fit the criteria of self-reported dyspareunia. 10 entered the enrollment process, only 7 completed. 2 discontinued the study due to out of state travel and 1 due to partners sudden illness. FSFI scores showed improvements in all 6 domains, including a decrease in pain and vaginal dryness. Conclusion: The initial data suggests larger enrollment and data collection will be necessary. Further research into the vaginal microbiome and its role in vaginal function is needed.
Sigma Membership
Rho Epsilon
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Menopause, Dyspareunia, Probiotics
Recommended Citation
Neu, Ellen L., "Menopausal Dyspareunia and Probiotics: A Future Approach?" (2016). INRC (Congress). 1.
https://www.sigmarepository.org/inrc/2015/presentations_2015/1
Conference Name
26th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
San Juan, Puerto Rico
Conference Year
2015
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
Menopausal Dyspareunia and Probiotics: A Future Approach?
San Juan, Puerto Rico
Session presented on Saturday, July 25, 2015: Purpose: A pilot study was conducted for the inquiry of vaginal probiotics for menopausal women with self-reported dyspareunia. Methods: Initial menopausal survey tool for assessment of urinary incontinence, dyspareunia and general vasomotor complaints allowed for women with self-reported dyspareunia to be further evaluated. potential candidates where then contacted and offered the opportunity to participate in an open lable study using a vaginal probiotic once per week for 6 weeks. After full disclosure and IRB approved consent was signed, the subjects examined and vaginal ph measurement obtained. The Female Sexual Function Index (FSFI, 2002) was administered. After 6 weeks of intervention, the women returned, repeated the FSFI and were examined with vaginal ph reassesed. A diary of dates and times probiotic was used and sexual intercourse took place was kept during the study and turned in to the PI. Results: 107 menopausal women were screened, 37 fit the criteria of self-reported dyspareunia. 10 entered the enrollment process, only 7 completed. 2 discontinued the study due to out of state travel and 1 due to partners sudden illness. FSFI scores showed improvements in all 6 domains, including a decrease in pain and vaginal dryness. Conclusion: The initial data suggests larger enrollment and data collection will be necessary. Further research into the vaginal microbiome and its role in vaginal function is needed.